Skip to content

A Study to Evaluate Oral Malodor and Other Outcomes Following The Use of Two-Step Toothpaste Oral Hygiene

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02613130
Enrollment
60
Registered
2015-11-24
Start date
2015-11-30
Completion date
2015-12-31
Last updated
2017-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Malodor

Brief summary

This study will assess changes in oral malodor and other factors in response to using a two-step toothpaste oral hygiene relative to a sensitivity whitening toothpaste.

Interventions

Sponsors

Procter and Gamble
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be at least 18 years of age; * Provide written informed consent prior to participation and be given a signed copy of the informed consent form; * Be in general good health as determined by the Investigator based on a review of the health history/update for participation in the trial; * Have an average hedonic score of at least 6.5; * Have at least 16 gradable teeth; * Have at least 10 bleeding sites; * Have a Lobene composite stain score of ≥1 on at least 1 tooth; * Have at least one test tooth with recession and a score of 6 or greater on the nine-point comfort/discomfort sensitivity scale; * Agree to return for scheduled visits and follow the study procedures; * Agree to refrain from use of any non-study oral hygiene products for the duration of the study; * Agree to refrain from tongue brushing for the duration of the study; * Agree to delay any elective dentistry, including dental prophylaxis, until the completion of the study; * Agree to abstain from eating, drinking, chewing gum, using tobacco products, and any oral hygiene at least eight hours prior to evaluation of oral malodor; and * Agree to refrain from using deodorant, body lotion/powder/spray, hair products, perfume/cologne, lipstick/gloss, or any other scented products on the mornings of the evaluation days prior to their visit to the clinic.

Exclusion criteria

* Oral malodor of systemic origin as determined by health history or examination; * Severe periodontal disease, as characterized by purulent exudate, generalized mobility, and/or severe recession; * Active treatment for periodontitis; * Removable oral appliances; * Fixed facial or lingual orthodontic appliances; * Antibiotic use within four weeks of the Screening visit; * Any disease or condition that might interfere with the safe participation in the study; and * Inability to undergo study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Breath odorBaselineBreath measured using a hedonic malodor evaluation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026